Doktorlar

DOÇ.DR. HAKAN ÖZTÜRK

Eğitim ve Uzmanlık

  • 1992-1997 ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ
  • 1998 - 2003 1998 - 2003 İZMİR ATATÜRK EĞİTİM VE ARAŞTIRMA HASTANESİ ÜROLOJİ KLİNİĞİ
  • 2018-2023 İZMİR EKONOMİ ÜNİVERSİTESİ ÜROLOJİ KLİNİĞİ

Deneyim

  • Asist.Dr. İzmir Atatürk Eğitim ve Araştırma Hastanesi 1998-2003
  • Uzman Dr. İzmir Basmane Şifa Hastanesi 2004-2013
  • Yrd.Doç.Dr İzmir Basmane Şifa Hastanesi, Şifa Üniversitesi Tıp Fakültesi 2013-2016
  • Yrd.Doç.Dr Medical Park İzmir Hastanesi, İzmir Üniversitesi Tıp Fakültesi 2016-2016
  • Uzman Dr. Medical Park İzmir Hastanesi 2016-2018
  • Doç. Dr. Medical Point Hastanesi, İzmir Ekonomi Üniversitesi 2018-2023

Mesleki Üyelikleri

  • American Society Of Clinical Oncology
  • European Association Of Urology
  • European Society For Medical Oncology
  • American Society For Radiation Oncology
  • European Society For Radiotherapy And Oncology
  • European Society Of Surgical Oncology
  • International Society Of Geriatric Oncology
  • American Association For Cancer Research
  • European Association For Cancer Research
  • Urological Association Of Asia
  • Türk Üroloji Derneği
  • Türk Androloji Derneği
  • Endoüroloji Derneği

Araştırma Yayınları

Uluslararası hakemli dergilerde yayımlanan makaleler:

  • 1-Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724. Epub 2015 Jan 16.
  • 2-Öztürk H. Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer Res Treat. 2015 Feb 12. doi: 10.4143/crt.2014.157. [Epub ahead of print]
  • 3-Öztürk H. Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy using plasma-button vaporization. Scand J Urol. 2015 Feb 19:1-6. [Epub ahead of print]
  • 4-Saracoglu M, Öztürk H, Duran A , Atalay S. Effect of microorganisms on etiology of hematospermia. Arch Ital Urol Androl. 2015 Mar 31;87(1):80-2.
  • 5-Öztürk H. High-grade Primary Renal Leiomyosarcoma. Int Braz J Urol. 2015 Mar-Apr;41(2):304-311.
  • 6-Öztürk H. Diagnostic role of 18f-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma. Minerva Urol Nefrol. 2015 Apr 28. [Epub ahead of print]
  • 7-Öztürk H. Tubeless versus standard PCNL in geriatric population. Actas Urol Esp. 2015 Apr 30. pii: S0210-4806(15)00119-9. doi: 10.1016/j.acuro.2015.02.010. [Epub ahead of print]
  • 8-Saraçoglu M, Öztürk H,Duran A,Atalay S. The Microorganisms Isolated From Urine And Ejaculate Samples And The Antibiotic Susceptibilities – Kasmera, 43(1), 155-163.
  • 9-Öztürk H. Comparing RECIST with EORTC Criteria in Metastatic Bladder Cancer J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94. doi: 10.1007/s00432-015-2022-2. Epub 2015 Jul 25.
  • 10-Saracoglu M, Öztürk H, Duran A , Atalay S. The Relationship Between Coronal Sulcus Lymphangitis And IgE Rev Int Androl. 2016;14(1):8-12. doi:10.1016/j.androl.2015.07.006
  • 11-Karaarslan S, Yaman B, Öztürk H, Kumbaraci BS. Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters. J Pathol Transl Med. 2015 Sep;49(5):389-95. doi: 10.4132/jptm.2015.08.10. Epub 2015 Sep 16.
  • 12-Öztürk H, Karapolat I. 18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer. Oncol Lett. 2016 Jan;11(1):316-322. Epub 2015 Nov 10.
  • 13-Öztürk H. Penile Mondor's Disease. Basic and Clinical Andrology 2014, 24:5 doi:10.1186/2051-4190-24-5.
  • 14-Saraçoglu M, Öztürk H. Female Circumcision. Andrology & Gynecology: Current Research 2014, 2:2 http://dx.doi.org/10.4172/2327-4360.1000120
  • 15-Öztürk H. Gastrointestinal System Complications in Percutaneous Nephrolithotomy: A Systematic Review. . J Endourol. 2014 Nov;28(11):1256-67. doi: 10.1089/end.2014.0344. Epub 2014 Sep 5.
  • 16-Öztürk H. Elective Urological Surgery Following Coronary Stent Implantation To Whom, How To Do it?. Curr Urol. 2014 Oct;7(4):169-73. doi: 10.1159/000365670. Epub 2014 Aug 20. Review.
  • 17-Saraçoğlu M, Öztürk H, Zengin T, Gümüş B. Erkeklerde genital pirsing. Androloji bülteni 2014; Ara (59): 222-226.
  • 18-Saracoglu M, Zengin T, Öztürk H, Genc M. Female Genital Mutilation/Cutting Type 4. J Androl Gynaecol. 2014 Dec;2(4): 5.
  • 19-Öztürk H. Prognostic features of renal sarcomas (Review). Oncol Lett. 2015 Mar;9(3):1034-1038. Epub 2014 Dec 30.
  • 20-Öztürk H, Saraçoglu M, Karaarslan S, Zengin T, Gülşen A, Kalaycıoğlu S. A case of renal tuberculosis diagnosed during percutaneous nephrolithotomy. Case Reports in Clinical Medicine 2013 Vol.2, No.7, 411-414 http://dx.doi.org/10.4236/crcm.2013.27109
  • 21-Öztürk H, Sivrikoz ON. High-Grade Primary Spindle Cell Sarcoma of the Prostate: A Case Report and Review of the Literature. World J Oncol. 2013;4(6):258-261.
  • 22-Öztürk H, Karaaslan S. High-Grade Primary Leiomyosarcoma of the Kidney. World J Nephrol Urol. 2014;3(1):63-65 doi: http://dx.doi.org/10.14740/wjnu158e
  • 23-Öztürk H. Adrenal Ganglioneuroma Presenting As Left Renal Mass. World J Oncol. 2014;5(2):90-92. doi: http://dx.doi.org/10.14740/wjon783w
  • 24-Öztürk H. Renal Mucinous Tubular and Spindle Cell Carcinoma and (18)F-Fluorodeoxyglucose-PET/CT Findings. Clin Genitourin Cancer. 2014 Aug;12(4):e161-6. doi: 10.1016/j.clgc.2014.03.011. Epub 2014 Apr 2.
  • 25-Öztürk H. Vena Cava Invasion By Adrenal leiomyosarcoma. Rare tumors 2014 Jun 23;6(2):5275,55-6.
  • 26-Öztürk H. Intrarenal Pseudoaneurysm After Percutaneous Nephrolithotomy at Solitary Kidney. Nephro Urol Mon. 2014 Sep; 6(5): e19037.
  • 27-Öztürk H, Karaaslan S. Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5271-9.
  • 28-Öztürk H, Karaaslan S. Metachronous Adrenal Metastasis From Operated Contralateral Renal Cell Carcinoma With Adrenalectomy And Iatrojenic Addison Disease. Can Urol Assoc J 2014;8(9-10):e744-8.
  • 29-Öztürk H, Multiple Carsinosarcomas Of The Kidney: A case report and review of the literature. Molecular and Clinical Oncology 2015 Jan (3): 212-216.
  • 30-Öztürk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Jun 11;82(2):114-7. doi: 10.5301/uro.5000094. Epub 2014 Nov 25.
  • 31-Öztürk H. 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney. Indian J Nucl Med 2015 Jan-Mar;30(1):68-71.
  • 32-Öztürk H. Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings. Urol Ann. 2015 Jan;7(1):115-19.
  • 33-Öztürk H. Peripheral neuroectodermal tumour of the kidney (Ewing’s sarcoma): Restaging with 18F-fluorodeoxyglucose (FDG)-PET/CT. Can Urol Assoc J 2015 Jan-Feb;9(1-2):E39-44.
  • 34-Öztürk H. Penile mucinous carcinoma: A case report. Oncol Lett. 2015 Mar;9(3):1293-1296. Epub 2014 Dec 30.
  • 35-Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol Lett. 2015 Apr;9(4):1897-1901. Epub 2015 Jan 28.
  • 36-Öztürk H. Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT. Int J Surg Case Rep. 2015 Apr 14;11:33-36. doi: 10.1016/j.ijscr.2015.04.017. [Epub ahead of print]
  • 37-Öztürk H. Penile Mondor's disease; diagnosis with magnetic resonance imaging. Revista Internacional de Andrologia; Jul-Sep. 2015;13(3):104-108.
  • 38-Öztürk H. Treatment of Colonic Injury During Percutaneous Nephrolithotomy. Rev Urol. 2015;17(3):194-201.
  • 39-Öztürk H. Facilitate Stent Removal: Magnetic DJ Stent. Urol Case Rep. 2017 Feb 2;11:55-56. doi: 10.1016/j.eucr.2016.11.021. eCollection 2017 Feb.
  • 40-Öztürk H. Re: Wong et al.: Is Percutaneous Nephrolithotomy in Solitary Kidneys Safe? (Urology 2013;82:1013-1016). Urology. 2014 Apr;83(4):959. doi: 10.1016/j.urology.2013.12.058.
  • 41-Öztürk H. How real is the uterine transplantation? Ann Transplant. 2014 Feb 14;19:82-3. doi: 10.12659/AOT.889973.
  • 42-Öztürk H, Saracoglu M, Zengin T, Sivrikoz ON, Kerman HS, Adakan S. Asymptomatic Sertoli cell tumour diagnosed during azoospermia work-up. Asian J Androl. 2013 Nov;15(6):845-6. doi: 10.1038/aja.2013.101. Epub 2013 Oct 14.
  • 43-Öztürk H. Neurologic complications of percutaneus nephrolithotomy. Int Neurourol J. 2014 Mar;18(1):45-7. doi: 10.5213/inj.2014.18.1.45. Epub 2014 Mar 31.
  • 44-Öztürk H. Wireless Capsule Cystoscopy: How Near? How Far?. Open Journal of Urology, 2014, 4, 37-40. http://dx.doi.org/10.4236/oju.2014.44007
  • 45-Öztürk H. Re: Parikh GP, Sonde SR, Kadam P. Venous air embolism: A complication during percutaneous nephrolithotomy. Indian J Urol 2014;30(4):456-7.
  • 46-Öztürk H. Genetic architecture of renal cell carcinoma: Do we have to know? World J Urol. 2016 Jun;34(6):765-9. doi: 10.1007/s00345-015-1697-y.
  • 47-Öztürk H. How do PDE5 Inhibutors close to solution at the treatment of BPH? J Clin Pharmacol. 2016 Apr;56(4):381-2. doi: 10.1002/jcph.623. Epub 2015 Oct 20.
  • 48-Öztürk H. Evaluation of Bosniak Type IIF and III Renal Cysts with Contrast-enhanced Ultrasound. Journal of the Belgian Society of Radiology, 100(1): 12, pp. 1–2, 2016. DOI: http://dx.doi.org/10.5334/jbr-btr.843
  • 49-Öztürk H. Mitochondria Transplantation: Why?, J Reprod Med. 2016 Mar-Apr;61(3-4):182-4.


Ulusal Yayınları

  • Solak A, Öztürk H, Sahin N,Saraçoğlu M,Kalaycıoğlu S,Genç B (2013). Mesane çıkısı obstrüksiyonunun non invaziv tanısında intravezikal prostatik protüzyonun önemi Semptomlar ve üroflovmetrik sonuçlarla korelasyon. Yeni Tıp Dergisi(30), 220-223.
  • Öztürk H (2013). Prostat Kanseri Tedavisinin Gelecegi Apopitoz mu. The Cystoscope, 1(1),6-9.
    Zengin T,Saraçoğlu M,Karaarslan S, Öztürk H (2013). Spermatik Kordda Adrenal Ektopik Doku ve Testisde Spermatositik
  • SeminomBirlikteligi Literatüre Kısa Bakıs. The Cystoscope, 1(1), 55-57.
    Öztürk H,Saraçoğlu M,Zengin T,Kerman HS (2013). Benign Prostat Hiperplazisi ve Asırı Aktif Mesane BirlikteligineGüncel Bakıs. Türkiye Klinikleri Uroloji, Dergisi, 4(2), 82-87., Doi: 1309-632X.
  • Saraçoğlu M, Öztürk H, Zengin T (2014). Ürodinamik Çalısmaların Tedavinin Yönlendirilmesine Katkısı Nedir?. The Cystoscope , 1(3), 189-195.
  • Öztürk H,,Gümüş BH (2014). Metabolik sendrom ve kadınlarda seksüel disfonksiyon. Androloji Bülteni, 16(56), 77-82.
  • Öztürk H, (2014). Geriatrik Popülasyonda Alfa-Bloker ve Antikolinerjik Kullanımının Sistemik Etkileri.. Akademik Geriatri Dergisi, 6(2), 62-72.
  • Saraçoğlu M, Öztürk H, Zengin T,Gümüş BH (2014). Erkeklerde genital pirsing. Androloji Bülteni, 16(59), 222-226.
  • Üşar P,Kar AA,Maral J,Yalaz S, Öztürk H, (2014). Genel Anestezi Sonrası Gelisen Negatif Basınç Akciger Ödemi. Journal of Anesthesia - JARSS, 22(2), 116- 19.
  • Yalçın M, Saklamaz A, Doğan F, Öztürk H,Aykır H,Yılmaz H (2015). Ciddi Hipolaksemi Gelisen Yaygın Osteoblastik Kemik Metastazlı Prostat Kanserli Bir Hasta.. Ege Klinikleri Tıp Dergisi, 53(1), 144-148.
  • Öztürk H, (2017). Evaluation of Response to Therapy Using 18FDG-PET/CT Before and AfterGemcitabine plus Cisplatin-Based Chemotherapy for Metastatic Bladder Cancer. Uluslararası Hematoloji Onkoloji Dergisi.

Kitap Yazarlığı

  • Dinçel Ç, Öztürk H. Mesane kanserinde lenfadenektomi. Üroonkoloji, 1. Basım. Editör: Dinçel Ç. Meta basım. İzmir:2007;421-429.